Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-24-006455
Filing Date
2024-11-13
Accepted
2024-11-13 09:45:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 AKERO THERAPEUTICS, INC. p24-3279sc13ga.htm SC 13G/A 60989
  Complete submission text file 0000902664-24-006455.txt   62597
Mailing Address 350 MADISON AVENUE 20TH FLOOR NEW YORK NY 10017
Business Address 350 MADISON AVENUE 20TH FLOOR NEW YORK NY 10017 2127166576
ALKEON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001230239 (see all company filings)

EIN.: 134200093 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Subject) CIK: 0001744659 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91047 | Film No.: 241451604
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)